Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP185954.RAKcPEyH1P3oVb30xFdlyd3SFIUofr9Y4AO3PMMnVJAck130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP185954.RAKcPEyH1P3oVb30xFdlyd3SFIUofr9Y4AO3PMMnVJAck130_assertion type Assertion NP185954.RAKcPEyH1P3oVb30xFdlyd3SFIUofr9Y4AO3PMMnVJAck130_head.
- NP185954.RAKcPEyH1P3oVb30xFdlyd3SFIUofr9Y4AO3PMMnVJAck130_assertion description "[Methylation frequencies of MLH1, MSH2, MSH6 and PMS2 promoter were 21.74%, 17.39%, 0% and 28.26% respectively in gastric cancer samples.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP185954.RAKcPEyH1P3oVb30xFdlyd3SFIUofr9Y4AO3PMMnVJAck130_provenance.
- NP185954.RAKcPEyH1P3oVb30xFdlyd3SFIUofr9Y4AO3PMMnVJAck130_assertion evidence source_evidence_literature NP185954.RAKcPEyH1P3oVb30xFdlyd3SFIUofr9Y4AO3PMMnVJAck130_provenance.
- NP185954.RAKcPEyH1P3oVb30xFdlyd3SFIUofr9Y4AO3PMMnVJAck130_assertion SIO_000772 19181186 NP185954.RAKcPEyH1P3oVb30xFdlyd3SFIUofr9Y4AO3PMMnVJAck130_provenance.
- NP185954.RAKcPEyH1P3oVb30xFdlyd3SFIUofr9Y4AO3PMMnVJAck130_assertion wasDerivedFrom befree-20140225 NP185954.RAKcPEyH1P3oVb30xFdlyd3SFIUofr9Y4AO3PMMnVJAck130_provenance.
- NP185954.RAKcPEyH1P3oVb30xFdlyd3SFIUofr9Y4AO3PMMnVJAck130_assertion wasGeneratedBy ECO_0000203 NP185954.RAKcPEyH1P3oVb30xFdlyd3SFIUofr9Y4AO3PMMnVJAck130_provenance.